Biomerica Secures Patents for inFoods® in GERD, Crohn’s, UC
21 Nov 2024 //
GLOBENEWSWIRE
Nasdaq Grants Biomerica 180 More Days for Listing Compliance
07 Nov 2024 //
GLOBENEWSWIRE
Biomerica Announces Direct-to-Consumer inFoods® IBS Test
30 Oct 2024 //
GLOBENEWSWIRE
Biomerica Reports First Quarter Fiscal 2025 Financial Results
16 Oct 2024 //
GLOBENEWSWIRE
SFDA Approves Biomerica`s At-Home PSA Screening Test
04 Sep 2024 //
GLOBENEWSWIRE
Biomerica Reports Fiscal 2024 Year End Results
29 Aug 2024 //
GLOBENEWSWIRE
Biomerica Announces IBS Pilot Launch With Physician Group In June 2024
13 May 2024 //
GLOBENEWSWIRE
Diagnostics Industry Leader Gary Huff Appointed to Biomerica Advisory Board
21 Feb 2024 //
GLOBENEWSWIRE
Biomerica Reports First Quarter 2024 Financial Results
13 Oct 2023 //
GLOBENEWSWIRE
REPEAT - Biomerica Reports First Quarter 2024 Financial Results
13 Oct 2023 //
GLOBENEWSWIRE
Biomerica Reports Fiscal 2023 Year End Results
25 Aug 2023 //
GLOBENEWSWIRE
CVS Health to Begin In-Store Sales of Biomerica`s EZ Detect Screening Test
03 Aug 2023 //
GLOBENEWSWIRE
Biomerica Receives Notice of Patent Allowance China for a Potential Technology
21 Jun 2023 //
GLOBENEWSWIRE
inFoods IBS Test Now Validated for Use
18 May 2023 //
GLOBENEWSWIRE
Biomerica Reports Q3 Fiscal 2023 Results
14 Apr 2023 //
GLOBENEWSWIRE
Biomerica announces the Launch of InFoods IBS as a LDT
08 Mar 2023 //
GLOBENEWSWIRE
Biomerica Announces Closing of $8M Underwritten Public Offering of Common Stock
07 Mar 2023 //
GLOBENEWSWIRE
Biomerica Announces Pricing of $8 Million Underwritten Public Offering of Stock
03 Mar 2023 //
GLOBENEWSWIRE
Biomerica Announces Proposed Underwritten Public Offering of Common Stock
02 Mar 2023 //
GLOBENEWSWIRE
Biomerica Reports Financial Results for Fiscal 2023 Q2 Ended November 30, 2022
13 Jan 2023 //
GLOBENEWSWIRE
Biomerica Appoints Mayo Clinic Gastroenterologist, Dr. Brian E. Lacy, to Board
10 Jan 2023 //
GLOBENEWSWIRE
Biomerica InFoods IBS Data Presented at the 2022 ACG Meeting
02 Nov 2022 //
GLOBENEWSWIRE
Biomerica’s Aware® Breast Self Exam and EZ Detect™ Colon Disease
29 Sep 2022 //
GLOBENEWSWIRE
Biomerica Plans Launch of InFoods® IBS Test; Names Robert Carlson asCCO
30 Aug 2022 //
GLOBENEWSWIRE
Biomerica to Participate at BTIG Biotech Conference
23 Jun 2022 //
GLOBENEWSWIRE
Biomerica Announces CE Mark for Its H. pylori Diagnostic Test, hp+detect™
12 May 2022 //
GLOBENEWSWIRE
Biomerica Announces FDA Submission For a Test to Detect Helicobacter pylori
26 Apr 2022 //
GLOBENEWSWIRE
Biomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6M
14 Apr 2022 //
GLOBENEWSWIRE
Biomerica Announces Positive Topline Results from the Endpoint Trial
08 Feb 2022 //
GLOBENEWSWIRE
Biomerica Reports Record Financial Results for Fiscal Q2 2021
13 Jan 2022 //
GLOBENEWSWIRE
Biomerica expects final patient for its InFoods Therapy IBS Trial this week
30 Aug 2021 //
GLOBENEWSWIRE
Biomerica Launches Website For Its EZ Detect™ Colorectal Disease Screening Test
05 Aug 2021 //
GLOBENEWSWIRE
Biomerica Signs Exclusive Distribution Agreement in Canada for hp+detect™
24 Jun 2021 //
GLOBENEWSWIRE
Biomerica Receives Notice of Allowance from Mexican Patent Office
15 Jun 2021 //
GLOBENEWSWIRE